Vasospastic heart failure: Multiple spasm may cause transient heart failure?

Journal of Cardiology

Volumn 54, Issue 3, 2009, Pages 452-459

  Sueda, Shozo ^a   Kohno, Hiroaki ^a   Oshita, Akira ^a   Izoe, Yousuke ^a   Nomoto, Takahiko ^a   Fukuda, Hiroshi ^a  

^a Saiseikai Saijo Hospital   (Japan)

Author keywords

Coronary artery spasm; Heart failure; Japan; Spasm provocation test

Indexed keywords

ACETYLCHOLINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERGOMETRINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; NICORANDIL; NITRATE; SPIRONOLACTONE;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; ARTIFICIAL VENTILATION; CARDIAC PATIENT; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY SPASM; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; DYSPNEA; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; OXYGEN BREATHING; PLEURA EFFUSION; PROTEIN BLOOD LEVEL; PROVOCATION TEST; SYSTOLE; THORAX PAIN; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; VALVULAR HEART DISEASE;

ACUTE-PHASE REACTION; ADRENERGIC BETA-ANTAGONISTS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CALCIUM CHANNEL BLOCKERS; CORONARY VASOSPASM; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PYRIMIDINES; PYRROLES; RISK FACTORS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 70450222322     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.07.007     Document Type: Article

References (22)

1. Kimura E., and Kishida H. Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan. Circulation 63 (1981) 844-848
2. Nakamura M., Takeshita A., and Nose Y. Clinical characteristics associated with myocardial infarction, arrhythmia, and sudden death in patients with vasospastic angina. Circulation 75 (1987) 1110-1116
3. Yasue H., Takizawa A., Nagao M., Nishida S., Horie M., Kubota J., Omote S., Takaoka K., and Okumura K. Long-term prognosis for patients with variant angina and influential factors. Circulation 78 (1988) 1-9
4. Shimokawa H., Nagasawa K., Irie T., Egashira S., Egashira K., Sagara T., Kikuchi Y., and Nakamura M. Clinical characteristics and long-term prognosis of patients with variant angina: a comparative study between western and Japanese populations. Int J Cardiol 18 (1988) 331-349
5. Sakata K., Nawada R., Ohbayashi K., Tamekiyo H., and Yoshida H. Diffuse and severe left ventricular dysfunction induced by epicardial coronary artery spasm. Angiology 51 (2000) 837-847
6. Nishi I., Iida K., Kawano S., Masumi T., Fumikura Y., Ohtsuka S., Watanabe S., and Yamaguchi I. Effects of anti-vasospastic agents in Japanese patients with dilated cardiomyopathy and coronary vasospasm. Jpn Heart J 43 (2002) 333-342
7. Richardson P., McKenna W., and Bristow M. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93 (1996) 841-859
8. WHO Expert Committee on Diabetes Mellitus. Second Report: World Health Organization Tech Report Series 646. Geneva: WHO; 1980.
9. World Health Organization Expert Committee. Arterial hypertension. WHO Technical Report Series 1978;(628):7-11.
10. Sueda S., Kohno H., Fukuda H., Ochi N., Kawada H., Hayashi Y., and Uraoka T. Frequency of provoked coronary spasms in patients undergoing coronary arteriography using a spasm provocation test via intracoronary administration of ergonovine. Angiology 55 (2004) 403-411
11. Sueda S., Kohno H., Fukuda H., Inoue K., Suzuki J., Watanabe K., Ochi T., and Uraoka T. Clinical and angiographical characteristics of acetylcholine induced spasm: relationship to dose of intracoronary injection of acetylcholine. Coron Artery Dis 13 (2002) 231-236
12. Sueda S., Saeki H., Otani T., Mineoi K., Kondou T., Yano K., Ochi T., Ochi N., Hayashi Y., Tsuruoka T., Kawada H., Matsuda S., and Uraoka T. Major complications during spasm provocation tests with an intracoronary injection of acetylcholine. Am J Cardiol 85 (2000) 391-394
13. Sueda S., Kohno H., Fukuda H., Ochi N., Kawada H., Hayashi Y., and Uraoka T. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations. Coron Artery Dis 15 (2004) 491-497
14. Packer M., Coats A.J.S., Fowler M.B., Katus H., Krum H., Mohacsi P., Rouleau J.L., Tendera M., Castaigne A., Roecker E.B., Schultz M.K., and DeMets D.L. Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344 (2001) 1651-1658
15. Hori M., Sasayama S., Kitabatake A., Toyo-oka T., Handa S., Yokoyama M., Matsuzaki M., Takeshita A., Origasa H., Matsui K., Hosoda S., and MUCHA Investigators. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. Am Heart J 147 (2004) 324-330
16. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., and Shusterman N.H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
17. Dargie H.J. Effects of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 357 (2001) 1385-1390
18. Nosaka H., and Nobuyoshi M. Coronary arterial spasm and symptomatology in ischemic and nonischemic heart disease: study of the ergonovine maleate provocation test in 3000 consecutive patients. J Cardiol Suppl. 12 (1987) 35-47
19. Beltrame J.F., Sasayama S., and Maseri A. A racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol 33 (1999) 1442-1452
20. Sueda S., Ochi N., Kawada H., Matsuda S., Hayashi Y., Tsuruoka T., and Uraoka T. Frequency of provoked coronary vasospasm in patients undergoing coronary arteriography with spasm provocation test of acetylcholine. Am J Cardiol 83 (1999) 1186-1190
21. Pristipino C., Beltrame J.F., Finocchiaro M.L., Hattori R., Fujita M., Mongiardo R., Cianflone D., Sanna T., Sasayama S., and Maseri A. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 101 (2000) 1102-1108
22. Sueda S., Kohno H., Fukuda H., Ochi N., Kawada H., Hayashi Y., and Uraoka T. Induction of coronary artery spasm by two pharmacological agents: comparison between intracoronary injection of acetylcholine and ergonovine. Coron Artery Dis 14 (2003) 451-457